1. Petty GW, Brown RD Jr, Whisnant JP, Sicks JD, O’Fallon WM, Wiebers DO. Ischemic stroke subtypes: a population-based study of incidence and risk factors. Stroke. 1999;30:2513–2516.
2. Barnett HJM, Taylor DW, Haynes RB, Sackett DL, Peerless SJ, Ferguson GG, Fox AJ, Rankin RN, Hachinski VC, Wiebers DO, et al. Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade carotid stenosis. N Engl J Med. 1991;325:445–453.
3. Walker MD, Marler JR, Goldstein M, Grady PA, Toole JF, Baker WH, Castaldo JE, Chambless LE, Moore WS, Robertson JT, et al. Endarterectomy for asymptomatic carotid artery stenosis. JAMA. 1995;273:1421–1428.
4. Naghavi M, Libby P, Falk E, Casscells SW, Litovsky S, Rumberger J, Badimon JJ, Stefanadis C, Moreno P, Pasterkamp G, et al. From vul- nerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: part I. Circulation. 2003;108:1664–1672.
5. Glagov S, Weisenberg E, Zarins CK, Stankunavicius R, Kolettis GJ. Compensatory enlargement of human atherosclerotic coronary arter- ies. N Engl J Med. 1987;316:1371–1375.
6. Alfonso F, Macaya C, Goicolea J, Iniguez A, Hernandez R, Zamorano J, Perez-Vizcayne MJ, Zarco P. Intravascular ultrasound imaging of angio- graphically normal coronary segments in patients with coronary artery disease. Am Heart J. 1994;127:536–544.
7. Nakamura M, Nishikawa H, Mukai S, Setsuda M, Nakajima K, Tamada H, Suzuki H, Ohnishi T, Kakuta Y, Nakano T, et al. Impact of coronary artery remodeling on clinical presentation of coronary artery disease: an intravascular ultrasound study. J Am Coll Cardiol. 2001;37:63–69.
8. Yoshida K, Fukumitsu R, Kurosaki Y, Funaki T, Kikuchi T, Takahashi JC, Takagi Y, Yamagata S, Miyamoto S. The association between expansive arterial remodeling detected by high-resolution MRI in carotid artery stenosis and clinical presentation. J Neurosurg. 2015;123:434–440.
9. Kurosaki Y, Yoshida K, Fukumitsu R, Sadamasa N, Handa A, Chin M, Yamagata S. Carotid artery plaque assessment using quantitative expansive remodeling evaluation and MRI plaque signal intensity. J Neurosurg. 2016;124:736–742.
10. Ivan E, Khatri JJ, Johnson C, Magid R, Godin D, Nandi S, Lessner S, Galis ZS. Expansive arterial remodeling is associated with in- creased neointimal macrophage foam cell content: the murine model of macrophage-rich carotid artery lesions. Circulation. 2002;105:2686–2691.
11. Ota R, Kurihara C, Tsou TL, Young WL, Yeghiazarians Y, Chang M, Mobashery S, Sakamoto A, Hashimoto T. Roles of matrix metallopro- teinases in flow-induced outward vascular remodeling. J Cereb Blood Flow Metab. 2009;29:1547–1558.
12. Allahverdian S, Chehroudi AC, McManus BM, Abraham T, Francis GA. Contribution of intimal smooth muscle cells to cholesterol accumula- tion and macrophage-like cells in human atherosclerosis. Circulation. 2014;129:1551–1559.
13. Vengrenyuk Y, Nishi H, Long X, Ouimet M, Savji N, Martinez FO, Cassella CP, Moore KJ, Ramsey SA, Miano JM, et al. Cholesterol load- ing reprograms the microRNA-143/145–myocardin axis to convert aor- tic smooth muscle cells to a dysfunctional macrophage-like phenotype. Arterioscler Thromb Vasc Biol. 2015;35:535–546.
14. Rosenfeld ME. Converting smooth muscle cells to macrophage-like cells with KLF4 in atherosclerotic plaques. Nat Med. 2015;21:549–551.
15. Bennett MR, Sinha S, Owens GK. Vascular smooth muscle erosclerosis. Circ Res. 2016;118:692–702.
16. Grootaert MO, Moulis M, Roth L, Martinet W, Vindis C, Bennett MR, De Meyer GR. Vascular smooth muscle cell death, autophagy and senes- cence in atherosclerosis. Cardiovasc Res. 2018;114:622–634.
17. Chappell J, Harman JL, Narasimhan VM, Yu H, Foote K, Simons BD, Bennett MR, Jørgensen HF. Extensive proliferation of a subset of differ- entiated, yet plastic, medial vascular smooth muscle cells contributes to neointimal formation in mouse injury and atherosclerosis models. Circ Res. 2016;119:1313–1323.
18. Chaabane C, Coen M, Bochaton-Piallat ML. Smooth muscle cell phe- notypic switch: implications for foam cell formation. Curr Opin Lipidol. 2014;25:374–379.
19. Donato R, Cannon BR, Sorci G, Riuzzi F, Hsu K, Weber DJ, Geczy CL. Functions of S100 proteins. Curr Mol Med. 2013;13:24–57.
20. Bjørnland K, Winberg JO, Ødegaard OT, Hovig E, Loennechen T, Aasen AO, Fodstad Ø, Mælandsmo GM. S100A4 involvement in metasta- sis: deregulation of matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases in osteosarcoma cells transfected with an anti-S100A4 ribozyme. Cancer Res. 1999;59:4702–4708.
21. Stewart RL, Carpenter BL, West DS, Knifley T, Liu L, Wang C, Weiss HL, Gal TS, Durbin EB, Arnold SM, et al. S100A4 drives non-small cell lung cancer invasion, associates with poor prognosis, and is effec- tively targeted by the FDA-approved anti-helminthic agent niclosamide. Oncotarget. 2016;7:34630–34642.
22. Coen M, Marchetti G, Palagi PM, Zerbinati C, Guastella G, Gagliano T, Bernardi F, Mascoli F, Bochaton-Piallat ML. Calmodulin expression dis- tinguishes the smooth muscle cell population of human carotid plaque. Am J Pathol. 2013;183:996–1009.
23. Nam D, Ni CW, Rezvan A, Suo J, Budzyn K, Llanos A, Harrison D, Giddens D, Jo H. Partial carotid ligation is a model of acutely induced disturbed flow, leading to rapid endothelial dysfunction and atheroscle- rosis. Am J Physiol Heart Circ Physiol. 2009;297:H1535–H1543.
24. Puchtler H, Waldrop FS. On the mechanism of Verhoeff’s elastica stain: a convenient stain for myelin sheaths. Histochemistry. 1979;62:233–247.
25. Gibson CM, Diaz L, Kandarpa K, Sacks FM, Pasternak RC, Sandor T, Feldman C, Stone PH. Relation of vessel wall shear stress to athero- sclerosis progression in human coronary arteries. Arterioscler Thromb. 1993;13:310–315.
26. Koskinas KC, Chatzizisis YS, Baker AB, Edelman ER, Stone PH, Feldman CL. The role of low endothelial shear stress in the conver- sion of atherosclerotic lesions from stable to unstable plaque. Curr Opin Cardiol. 2009;24:580–590.
27. Qi YX, Jiang J, Jiang XH, Wang XD, Ji SY, Han Y, Long DK, Shen BR, Yan ZQ, Chien S, et al. PDGF-BB and TGF-β1 on cross-talk between endothelial and smooth muscle cells in vascular remodeling induced by low shear stress. Proc Natl Acad Sci USA. 2011;108:1908–1913.
28. Chaabane C, Heizmann CW, Bochaton-Piallat ML. Extracellular S100A4 induces smooth muscle cell phenotypic transition mediated by RAGE. Biochim Biophys Acta. 2015;1853:2144–2157.
29. Yoshida K, Yang T, Yamamoto Y, Kurosaki Y, Funaki T, Kikuchi T, Ishii A, Kataoka H, Miyamoto S. Expansive carotid artery remodeling: pos- sible marker of vulnerable plaque. J Neurosurg. 2019:1–6. https://doi. org/10.3171/2019.7.JNS19727.
30. Sitzer M, Puac D, Buehler A, Steckel DA, von Kegler S, Markus HS, Steinmetz H. Internal carotid artery angle of origin: a novel risk factor for early carotid atherosclerosis. Stroke. 2003;34:950–955.
31. Nguyen KT, Clark CD, Chancellor TJ, Papavassiliou DV. Carotid geom- etry effects on blood flow and on risk for vascular disease. J Biomech. 2008;41:11–19.
32. Davies MJ, Richardson PD, Woolf N, Katz DR, Mann J. Risk of thrombosis in human atherosclerotic plaques: role of extracellu- lar lipid, macrophage, and smooth muscle cell content. Br Heart J. 1993;69:377–381.
33. Schneider M, Kostin S, Strom CC, Aplin M, Lyngbaek S, Theilade J, Grigorian M, Andersen CB, Lukanidin E, Lerche Hansen J, et al. S100A4 is upregulated in injured myocardium and promotes growth and survival of cardiac myocytes. Cardiovasc Res. 2007;75:40–50.
34. Waltenberger J. Modulation of growth factor action: implica- tions for the treatment of cardiovascular diseases. Circulation. 1997;96:4083–4094.
35. Gong XJ, Song XY, Wei H, Wang J, Niu M. Serum S100A4 levels as a novel biomarker for detection of acute myocardial infarction. Eur Rev Med Pharmacol Sci. 2015;19:2221–2225.
36. Olejarz W, Lacheta D, Gluszko A, Migacz E, Kukwa W, Szczepanski MJ, Tomaszewski P, Nowicka G. Rage and TLRs as key targets for antiath- erosclerotic therapy. Biomed Res Int. 2018;2018:7675286.
37. Grum-Schwensen B, Klingelhöfer J, Beck M, Bonefeld CM, Hamerlik P, Guldberg P, Grigorian M, Lukanidin E, Ambartsumian N. S100A4- neutralizing antibody suppresses spontaneous tumor progression, pre-metastatic niche formation and alters T-cell polarization balance. BMC Cancer. 2015;15:44.